EAPH - Easton Pharmaceuticals Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue-67.428--
Cost of Revenue-43.636--
Gross Profit-23.792--
Operating Expenses
Research Development133.669139.23592.91468.225
Selling General and Administrative502.037338.596248.842113.556
Non Recurring----
Total Operating Expenses635.706521.467341.756181.781
Operating Income or Loss-635.706-454.039-341.756-181.781
Income from Continuing Operations
Total Other Income/Expenses Net35.76593.191-4.777-1.5
Earnings Before Interest and Taxes-635.706-454.039-341.756-181.781
Interest Expense----
Income Before Tax-599.941-360.848-346.533-183.281
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-599.941-360.848-346.533-183.281
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-599.941-360.848-346.533-183.281
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-599.941-360.848-346.533-183.281